新诊断2型糖尿病患者住院期间低血糖发生的危险因素分析(4)
[11] Zhang Y， Zhao Z， Wang S，et al. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes[J].Diabetes Metab Res Rev，2017，33(7)：e2913.
[12] Porcellati F， Lin J， Lucidi P， et al. Impact of patient and treatment characteristics on glycemic control and hypoglyce mia in patients with type 2 diabetes initiated to insulin glargine or NPH： A post hoc， pooled， patient-level analysis of 6 randomized controlled trials[J].Medicine (Baltimore)，2017， 96(5)：e6022.
[13] CZECH MP. Insulin action and resistance in obesity and type 2 diabetes[J].Nat Med，2017，23(7)：804-814.
[14] 郭慶妍，朱翠玲，卜乐，等.不同体质量指数糖尿病患者胰岛素分泌及胰岛功能的特点[J].同济大学学报，2018，39(1)：83-88.
[15] Chung JO，Cho DH，Chung DJ， et al.Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes[J].J Diabetes Complications，2015，29(3)：350-355.
[16] 唐祝奇，崔世维，朱晓晖.空腹和餐后2 hC肽在评估2型糖尿病β细胞功能中的作用[J].中国老年学杂志，2014， 34(12)：3251-3252.
[17] Hope SV， Knight BA， Shields BM， et al. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia[J].Diabetologia，2018，61(1)：66-74.
(收稿日期：2020-07-05), http://www.100md.com(卓烨烨 吴逸希 蔡德)
[12] Porcellati F， Lin J， Lucidi P， et al. Impact of patient and treatment characteristics on glycemic control and hypoglyce mia in patients with type 2 diabetes initiated to insulin glargine or NPH： A post hoc， pooled， patient-level analysis of 6 randomized controlled trials[J].Medicine (Baltimore)，2017， 96(5)：e6022.
[13] CZECH MP. Insulin action and resistance in obesity and type 2 diabetes[J].Nat Med，2017，23(7)：804-814.
[14] 郭慶妍，朱翠玲，卜乐，等.不同体质量指数糖尿病患者胰岛素分泌及胰岛功能的特点[J].同济大学学报，2018，39(1)：83-88.
[15] Chung JO，Cho DH，Chung DJ， et al.Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes[J].J Diabetes Complications，2015，29(3)：350-355.
[16] 唐祝奇，崔世维，朱晓晖.空腹和餐后2 hC肽在评估2型糖尿病β细胞功能中的作用[J].中国老年学杂志，2014， 34(12)：3251-3252.
[17] Hope SV， Knight BA， Shields BM， et al. Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia[J].Diabetologia，2018，61(1)：66-74.
(收稿日期：2020-07-05), http://www.100md.com(卓烨烨 吴逸希 蔡德)